Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective

被引:20
作者
Miao, Li-na [1 ,2 ]
Pan, Deng [1 ,2 ]
Shi, Junhe [1 ]
Du, Jian-peng [1 ,3 ]
Chen, Peng-fei [1 ]
Gao, Jie [1 ,3 ]
Yu, Yanqiao [1 ,2 ]
Shi, Da-Zhuo [1 ,3 ]
Guo, Ming [1 ,3 ]
机构
[1] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dept Grad Sch, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, China Heart Inst Chinese Med, Beijing, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
cardiovascular disease; PKC-delta; kinase; mechanism; PKC; PROTEIN-KINASE-C; VASCULAR SMOOTH-MUSCLE; TISSUE GROWTH-FACTOR; PERCUTANEOUS CORONARY INTERVENTION; CA2+-ACTIVATED K+ CHANNELS; FOCAL ADHESION KINASE; ANGIOTENSIN-II; TYROSINE PHOSPHORYLATION; MYOCARDIAL-INFARCTION; ACTIVATION MECHANISMS;
D O I
10.3389/fcvm.2022.816369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein kinase C (PKC) is a protein kinase with important cellular functions. PKC-delta, a member of the novel PKC subfamily, has been well-documented over the years. Activation of PKC-delta plays an important regulatory role in myocardial ischemia/reperfusion (IRI) injury and myocardial fibrosis, and its activity and expression levels can regulate pathological cardiovascular diseases such as atherosclerosis, hypertension, cardiac hypertrophy, and heart failure. This article aims to review the structure and function of PKC-delta, summarize the current research regarding its activation mechanism and its role in cardiovascular disease, and provide novel insight into further research on the role of PKC-delta in cardiovascular diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Current Status of Cardiovascular Medicine in Israel
    Kornowski, Ran
    Orvin, Katia
    CIRCULATION, 2020, 142 (01) : 17 - 19
  • [32] Update on the Role of Colchicine in Cardiovascular Disease
    Darcy Banco
    Mohammad Mustehsan
    Binita Shah
    Current Cardiology Reports, 2024, 26 : 191 - 198
  • [33] Role of Circular RNAs in Cardiovascular Disease
    Kishore, Raj
    Garikipati, Venkata N. S.
    Gonzalez, Carolina
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (02) : 128 - 137
  • [34] Role of PKC-δ during hypoxia in heart-derived H9c2 cells
    Kim, MJ
    Moon, CH
    Kim, MH
    Lee, SH
    Baik, EJ
    Jung, YS
    JAPANESE JOURNAL OF PHYSIOLOGY, 2004, 54 (04) : 405 - 414
  • [35] Role of Lipoprotein(a) Reduction in Cardiovascular Disease
    Schuth, Uma
    Gill, Kieran
    Telyuk, Pyotr
    Bawamia, Bilal-Reshad
    Austin, David
    Zaman, Azfar
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [36] Update on the Role of Colchicine in Cardiovascular Disease
    Banco, Darcy
    Mustehsan, Mohammad
    Shah, Binita
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (04) : 191 - 198
  • [37] The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives
    Papadopoulos, Panagiotis D.
    Tsigalou, Christina
    Valsamaki, Pipitsa N.
    Konstantinidis, Theocharis G.
    Voidarou, Chrysoula
    Bezirtzoglou, Eugenia
    BIOMEDICINES, 2022, 10 (05)
  • [38] The emerging role of microRNAs in cardiovascular disease
    Maegdefessel, L.
    JOURNAL OF INTERNAL MEDICINE, 2014, 276 (06) : 633 - 644
  • [39] COVID-19 and Cardiovascular Disease: a Global Perspective
    Pina, Alessandra
    Castelletti, Silvia
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (10)
  • [40] Work stress and cardiovascular disease: a life course perspective
    Li, Jian
    Loerbroks, Adrian
    Bosma, Hans
    Angerer, Peter
    JOURNAL OF OCCUPATIONAL HEALTH, 2016, 58 (02) : 216 - 219